82 Anti-diabetic formulation namely AYUSH
Central Council for Research in Ayurvedic Sciences (CCRAS) in collaboration with Directorate General of Health Services, Ministry of Health & Family Welfare has implemented and executed a programme viz. Integration of AYUSH (Ayurveda) component with National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular diseases & Stroke (NPCDCS) programme in the identified districts of 3 states viz. Bhilwara (Rajasthan), Surendranagar (Gujarat) and Gaya (Bihar) to cater health care services and reduce the burden of NCDs by combining the strength of Ayurveda and Yoga. The programme was launched during Jan/Feb 2016 in 2 districts viz. Bhilwara (Rajasthan), Surendranagar (Gujarat) and in Gaya (Bihar) the programme was launched in April 2016.
The programme is successfully functional in 52 centers (49 CHCs and 3 District Hospitals) all 3 identified districts. Till December 2017, 241886 patients have been screened for selected Non Communicable Disease, out of which 54991 patients have been enrolled for selected NCDs under this programme and out of which 23699 Diabetic patients have been enrolled and given treatment, Dietary regimen and Yoga classes.
CCRAS has developed an anti-diabetic formulation namely AYUSH-82 and commercialized to several pharmaceutical companies through National Research Development Corporation (NRDC), New Delhi.
CSIR, has developed after standardization and pre-clinical studies conducted jointly by CSIR-CIMAP and CSIR-NBRI a formulation BGR34, which is meant to be used by patients of newly diagnosed diabetes only as a measure of management of the disease.